blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2999797

EP2999797 - ISOFORMS OF GATA6 AND NKX2-1 AS MARKERS FOR DIAGNOSIS AND THERAPY OF CANCER AND AS TARGETS FOR ANTI-CANCER THERAPY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.05.2019
Database last updated on 11.09.2024
FormerThe patent has been granted
Status updated on  01.06.2018
FormerGrant of patent is intended
Status updated on  07.01.2018
FormerRequest for examination was made
Status updated on  05.12.2017
FormerGrant of patent is intended
Status updated on  20.07.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
Hofgartenstrasse 8
80539 München / DE
For all designated states
Justus-Liebig-Universität Giessen
Ludwigstrasse 23
35390 Giessen / DE
[2018/27]
Former [2016/13]For all designated states
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
Hofgartenstrasse 8
80539 München / DE
For all designated states
Justus-Liebig- Universitat Giessen
Ludwigstrasse 23
35390 Giessen / DE
Inventor(s)01 / BARRETO, Guillermo
Luisenthalerstr. 14
61184 Karben / DE
02 / MEHTA, Aditi
Hermann Ehlers Straße 9
61231 Bad Nauheim / DE
03 / SINGH, Indrabahadur
Friedrich-Ebert-Straße 8
61169 Friedberg / DE
04 / SZIBOR, Marten
Niipperintie 26b
FIN-02920 Espoo / FI
05 / SAVAI, Rajkumar
Lessingstraße 1
61231 Bad Nauheim / DE
06 / SEEGER, Werner
Schafsweg 19
35444 Biebertal / DE
07 / BRAUN, Thomas
Höhenweg 20
61231 Bad Nauheim / DE
08 / GÜNTHER, Andreas
Bahnhofstraße 31
35415 Pohlheim Watzenborn-Steinberg / DE
09 / KRÜGER, Marcus
Schwalheimer Str. 9F
61231 Bad Nauheim / DE
 [2016/13]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2016/13]
Application number, filing date14731556.821.05.2014
[2016/13]
WO2014EP60489
Priority number, dateEP2013016862921.05.2013         Original published format: EP 13168629
EP2013016863621.05.2013         Original published format: EP 13168636
[2016/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014187881
Date:27.11.2014
Language:EN
[2014/48]
Type: A1 Application with search report 
No.:EP2999797
Date:30.03.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 27.11.2014 takes the place of the publication of the European patent application.
[2016/13]
Type: B1 Patent specification 
No.:EP2999797
Date:04.07.2018
Language:EN
[2018/27]
Search report(s)International search report - published on:EP27.11.2014
ClassificationIPC:C12Q1/68
[2016/13]
CPC:
C12Q1/6886 (EP,US); C12Q2600/112 (EP,US); C12Q2600/156 (EP,US);
C12Q2600/158 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/13]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:SPEZIFISCHE ISOFORMEN VON GATA6 UND NKX2-1 ALS NEUE MARKER ZUR DIAGNOSE UND FÜR THERAPIEANSÄTZE BEI KREBS UND ALS ZIELE ZUR BEHANDLUNG VON KREBS[2017/27]
English:ISOFORMS OF GATA6 AND NKX2-1 AS MARKERS FOR DIAGNOSIS AND THERAPY OF CANCER AND AS TARGETS FOR ANTI-CANCER THERAPY[2016/13]
French:ISOFORMES SPÉCIFIQUES DE GATA6 ET NKX2-1 EN TANT QUE NOUVEAUX MARQUEURS POUR LES APPROCHES DE DIAGNOSTIC ET DE THÉRAPIE DU CANCER ET EN TANT QUE CIBLES POUR LA THÉRAPIE ANTICANCÉREUSE[2017/27]
Former [2016/13]ISOFORMEN VON GATA6 UND NKX2-1 ALS MARKER ZUR DIAGNOSE UND THERAPIE VON KREBS UND ALS TARGETS ZUR KREBSTHERAPIE
Former [2016/13]ISOFORMES DE GATA6 ET DE NKX2-1 UTILISÉS EN TANT QUE MARQUEURS POUR LE DIAGNOSTIC ET LA CANCÉROTHÉRAPIE ET EN TANT QUE CIBLES POUR UNE THÉRAPIE ANTICANCÉREUSE
Entry into regional phase21.12.2015National basic fee paid 
21.12.2015Designation fee(s) paid 
21.12.2015Examination fee paid 
Examination procedure21.12.2015Examination requested  [2016/13]
27.07.2016Amendment by applicant (claims and/or description)
21.07.2017Communication of intention to grant the patent
30.11.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
30.11.2017Fee for grant paid
30.11.2017Fee for publishing/printing paid
08.01.2018Communication of intention to grant the patent
17.05.2018Receipt of the translation of the claim(s)
Divisional application(s)EP18181398.1  / EP3461909
Opposition(s)05.04.2019No opposition filed within time limit [2019/24]
Fees paidRenewal fee
30.03.2016Renewal fee patent year 03
23.05.2017Renewal fee patent year 04
23.05.2018Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU21.05.2014
AL04.07.2018
AT04.07.2018
CY04.07.2018
CZ04.07.2018
DK04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
LT04.07.2018
LV04.07.2018
MC04.07.2018
MK04.07.2018
MT04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SI04.07.2018
SK04.07.2018
SM04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
PT04.11.2018
[2022/31]
Former [2021/34]HU21.05.2014
AL04.07.2018
AT04.07.2018
CY04.07.2018
CZ04.07.2018
DK04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
LT04.07.2018
LV04.07.2018
MC04.07.2018
MT04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SI04.07.2018
SK04.07.2018
SM04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
PT04.11.2018
Former [2021/32]HU21.05.2014
AL04.07.2018
AT04.07.2018
CY04.07.2018
CZ04.07.2018
DK04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
LT04.07.2018
LV04.07.2018
MC04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SI04.07.2018
SK04.07.2018
SM04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
PT04.11.2018
Former [2021/26]AL04.07.2018
AT04.07.2018
CY04.07.2018
CZ04.07.2018
DK04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
LT04.07.2018
LV04.07.2018
MC04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SI04.07.2018
SK04.07.2018
SM04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
PT04.11.2018
Former [2020/29]AL04.07.2018
AT04.07.2018
CZ04.07.2018
DK04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
LT04.07.2018
LV04.07.2018
MC04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SI04.07.2018
SK04.07.2018
SM04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
PT04.11.2018
Former [2020/07]AL04.07.2018
AT04.07.2018
CZ04.07.2018
DK04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
LT04.07.2018
LV04.07.2018
MC04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SI04.07.2018
SK04.07.2018
SM04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2019/37]AL04.07.2018
AT04.07.2018
CZ04.07.2018
DK04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
LT04.07.2018
LV04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SI04.07.2018
SK04.07.2018
SM04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2019/26]AL04.07.2018
AT04.07.2018
CZ04.07.2018
DK04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
LT04.07.2018
LV04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SK04.07.2018
SM04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2019/24]AL04.07.2018
AT04.07.2018
CZ04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
LT04.07.2018
LV04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SK04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2019/22]AL04.07.2018
AT04.07.2018
CZ04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
LT04.07.2018
LV04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2019/12]AL04.07.2018
AT04.07.2018
CZ04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
LT04.07.2018
LV04.07.2018
NL04.07.2018
PL04.07.2018
RS04.07.2018
SE04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2019/11]AT04.07.2018
CZ04.07.2018
FI04.07.2018
HR04.07.2018
LT04.07.2018
NL04.07.2018
PL04.07.2018
RS04.07.2018
SE04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2019/10]AT04.07.2018
CZ04.07.2018
FI04.07.2018
LT04.07.2018
NL04.07.2018
PL04.07.2018
RS04.07.2018
SE04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2019/08]FI04.07.2018
LT04.07.2018
NL04.07.2018
NO04.10.2018
IS04.11.2018
Former [2019/07]LT04.07.2018
NL04.07.2018
Former [2019/04]NL04.07.2018
Cited inInternational search[A]WO2004060302  (CEMINES LLC [US], et al) [A] 1-27 * abstract * * claims 5-9, 22-28 *;
 [AD]  - MONTE M. WINSLOW ET AL, "Suppression of lung adenocarcinoma progression by Nkx2-1", NATURE, (20110406), vol. 473, no. 7345, doi:10.1038/nature09881, ISSN 0028-0836, pages 101 - 104, XP055081012 [AD] 1-27 * abstract *

DOI:   http://dx.doi.org/10.1038/nature09881
 [AD]  - J. KENDALL ET AL, "Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20070904), vol. 104, no. 42, doi:10.1073/pnas.0708286104, ISSN 0027-8424, pages 16663 - 16668, XP055081009 [AD] 1-27 * abstract *

DOI:   http://dx.doi.org/10.1073/pnas.0708286104
 [AD]  - M. GUO, "Hypermethylation of the GATA Genes in Lung Cancer", CLINICAL CANCER RESEARCH, (20041201), vol. 10, no. 23, doi:10.1158/1078-0432.CCR-04-1140, ISSN 1078-0432, pages 7917 - 7924, XP055081008 [AD] 1-27 * abstract *

DOI:   http://dx.doi.org/10.1158/1078-0432.CCR-04-1140
 [A]  - COULSON J M ET AL, "A Splice Variant of the Neuron-restrictive Silencer Factor Repressor Is Expressed in Small Cell Lung Cancer: A Potential Role in Depression of Neuroendocrine Genes and a Useful Clinical Marker", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, (20000401), vol. 60, ISSN 0008-5472, pages 1840 - 1844, XP003002388 [A] 1-27 * abstract *
 [A]  - MATSUMOTO R ET AL, "SHORT ALTERNATIVE SPLICE TRANSCRIPTS OF THE MDM2 ONCOGENE CORRELATE TO MALIGNANCY IN HUMAN ASTROCYTIC NEOPLASMS", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, (19980101), vol. 58, ISSN 0008-5472, pages 609 - 613, XP008071095 [A] 1-27 * abstract *
by applicantUS3773919
 EP0036676
 EP0052322
 EP0058481
 JPS58118008
 EP0088046
 DE3218121
 EP0102324
 US4485045
 EP0133988
 EP0142641
 EP0143949
 US4544545
    - HERBST RS ET AL., N ENGL J MED, (2008), vol. 359, no. 13, pages 1367 - 80
    - GUO M ET AL., CLIN CANCER RES., (2004), vol. 10, no. 23, pages 7917 - 24
    - KENDALL J ET AL., PROC NATL ACAD SCI USA., (2007), vol. 104, no. 42, pages 16663 - 8
    - TANG Y ET AL., CELL RES., (2011), vol. 21, no. 2, pages 316 - 26
    - ROLLIN ET AL., PLOS ONE, (2009), vol. 4, no. 1, page E4158
    - WINSLOW, NATURE, (2011), vol. 473, no. 7345, pages 101 - 104
    - LINDHOLM, JOURNAL OF CLINICAL PATHOLOGY, (2009), vol. 62, no. 4, pages 339 - 344
    - GORSHKOVE, BIOCHEMISTRY (MOSC, (2005), vol. 70, pages 1180 - 1184
    - MARGANA RK; BOGGARAM V., J BIOL CHEM., (1997), vol. 272, no. 5, pages 3083 - 90
    - MINOO P ET AL., DEV BIOL., (1999), vol. 209, no. 1, pages 60 - 71
    - KEIJZER R ET AL., DEVELOPMENT, (2001), vol. 128, no. 4, pages 503 - 11
    - WAN H ET AL., J BIOL CHEM., (2005), vol. 280, no. 14, pages 13809 - 16
    - WAN H ET AL., PROC NATL ACAD SCI USA., (2004), vol. 101, no. 40, pages 14449 - 54
    - ERAMO A ET AL., ONCOGENE, (2010), vol. 29, no. 33, pages 4625 - 35
    - EARLY DETECTION OF LUNG CANCER, SCIENCEDAILY, (20090509), URL: sciencedaily.com/releases/2009/05/090502093211.htm
    - HOWINGTON JA ET AL., CHEST JOURNAL, (2013), vol. 143, pages E278S - E313S
    - GOLDSTRAW P. ET AL., J THORAC ONCOL., (2007), vol. 2, no. 8, pages 706 - 14
    - BEADSMOORE CJ; SCREATON NJ, EUR J RADIOL., (2003), vol. 45, no. 1, pages 8 - 17
    - MOUNTAIN CF, CHEST, (1997), vol. 111, no. 6, pages 1710 - 7
    - SCHNEIDER, MOLECULAR THERAPY-NUCLEIC ACIDS, (2012), vol. 1, page E46
    - DOU, JOURNAL OF CONTROLLED RELEASE, (2012), vol. 16, pages 875 - 883
    - SONG, NATURE BIOTECHNOLOGY, (2005), vol. 23, no. 6, pages 709 - 717
    - TANG Y ET AL., CELL RES, (2011), vol. 21, no. 2, pages 316 - 26
    - ROLLIN J ET AL., PLOS ONE., (2009), vol. 4, no. 1, page E4158
    - MARGANA RK; BOGGARAM V, J BIOL CHEM., (1997), vol. 272, no. 5, pages 3083 - 90
    - WAN H ET AL., PROC NATL ACAD SCI U S A., (2004), vol. 101, no. 40, pages 14449 - 54
    - SIDMAN, U. ET AL., BIOPOLYMERS, (1983), vol. 22, pages 547 - 556
    - R. LANGER ET AL., J. BIOMED. MATER. RES., (1981), vol. 15, pages 167 - 277
    - R. LANGER, CHEM. TECH., (1982), vol. 12, pages 98 - 105
    - EPSTEIN ET AL., PROC. NATL. ACAD. SCI. (USA, (1985), vol. 82, pages 3688 - 3692
    - HWANG ET AL., PROC. NATL. ACAD. SCI. (USA, (1980), vol. 77, pages 4030 - 4034
    - HUGHES ET AL., DRUG DISCOVERY TODAY, (2001), vol. 6, pages 303 - 315
    - LIANG ET AL., EUR. J. BIOCHEM., (2002), vol. 269, pages 5753 - 5758
    - BECKER ET AL., In Antisense Technology in the Central Nervous System, OXFORD UNIVERSITY PRESS, pages 147 - 157
    - EFFROS ET AL., AM J RESPIR CRIT CARE MED., (2012), vol. 185, no. 8, pages 803 - 804
    - PRESTRIDGE, JOURNAL OF MOLECULAR BIOLOGY, (1995), vol. 249, pages 923 - 932
    - THIERRY-MIEG, GENOME BIOLOGY, (2006), vol. 7, no. 1, page 12
    - LIANG CC ET AL., NAT PROTOC., (2007), vol. 2, no. 2, pages 329 - 33
    - MANI, CELL, (2008), vol. 133, no. 4, pages 704 - 715
    - BISHOP JA ET AL., HUM PATHOL., (2010), vol. 41, no. 1, pages 20 - 5
    - KALHOR, MODERN PATHOLOGYL, (2006), vol. 9, pages 1117 - 1123
    - HOFFMAN PC ET AL., LANCET, (2000), vol. 355, no. 9202, pages 479 - 85
    - HYDE L; HYDE CL, CHEST, (1974), vol. 65, no. 3, pages 299 - 306
    - STRAUSS GM; DOMINIONI L, J SURG ONCOL, (2013), vol. 108, no. 5, pages 294 - 300
    - D'URSO V ET AL., J CELL PHYSIOL, (2013), vol. 228, no. 5, pages 945 - 51
    - TRAVIS WD ET AL., ARCH PATHOL LAB MED, (2013), vol. 137, no. 5, pages 668 - 84
    - KOLLA V ET AL., AM J RESPIR CELL MOL BIOL, (2007), vol. 36, no. 2, pages 213 - 25
    - ZHANG Y ET AL., DEVELOPMENT, (2007), vol. 134, no. 1, pages 189 - 98
    - TIAN Y ET AL., DEVELOPMENT, (2011), vol. 138, no. 7, pages 1235 - 45
    - GUO M ET AL., CLIN CANCER RES, (2004), vol. 10, no. 23, pages 7917 - 24
    - GORSHKOVA EV ET AL., BIOCHEMISTRY (MOSC, (2005), vol. 70, no. 10, pages 1180 - 4
    - LINDHOLM PM ET AL., J CLIN PATHOL, (2009), vol. 62, no. 4, pages 339 - 44
    - WINSLOW MM ET AL., NATURE, (2011), vol. 473, no. 7345, pages 101 - 4
    - CHEUNG WK ET AL., CANCER CELL, (2013), vol. 23, no. 6, pages 725 - 38
    - CHEN PM ET AL., CARCINOGENESIS, (2013), vol. 34, no. 11, pages 2655 - 63
    - HORVATH I ET AL., EUR RESPIR J, (2005), vol. 26, no. 3, pages 523 - 48
    - MONTUSCHI P, THER ADV RESPIR DIS, (2007), vol. 1, no. 1, pages 5 - 23
    - HO LP ET AL., THORAX, (1998), vol. 53, no. 8, pages 680 - 4
    - SHAHID SK ET AL., AM J RESPIR CRIT CARE MED, (2002), vol. 165, no. 9, pages 1290 - 3
    - HUSZAR E ET AL., EUR RESPIR J, (2002), vol. 20, no. 6, pages 1393 - 8
    - EFFROS RM ET AL., AM J RESPIR CRIT CARE MED, (2002), vol. 165, no. 5, pages 663 - 9
    - MONTUSCHI P ET AL., THORAX, (2003), vol. 58, no. 7, pages 585 - 8
    - KOSTIKAS K ET AL., EUR RESPIR J, (2003), vol. 22, no. 5, pages 743 - 7
    - EFFROS RM ET AL., AM J RESPIR CRIT CARE MED, (2012), vol. 185, no. 8, pages 803 - 4
    - DAVIS MD ET AL., IMMUNOL ALLERGY CLIN NORTH AM, (2012), vol. 32, no. 3, pages 363 - 75
    - KULLMANN T ET AL., PATHOL ONCOL RES, (2008), vol. 14, no. 4, pages 481 - 3
    - CARPAGNANO GE ET AL., LUNG CANCER, (2010), vol. 76, no. 1, pages 108 - 13
    - ZAKHARKINA T ET AL., RESPIROLOGY, (2011), vol. 16, no. 6, pages 932 - 8
    - XU Z ET AL., PLOS ONE, (2012), vol. 7, no. 7, page E41137
    - GESSNER C ET AL., LUNG CANCER, (2004), vol. 43, no. 2, pages 215 - 22
    - XIAO P ET AL., LUNG CANCER, (2014), vol. 83, no. 1, pages 56 - 60
    - IARC, MONOGR EVAL CARCINOG RISK CHEM HUM, (1986), vol. 38, pages 35 - 394
    - XU ZY ET AL., J NATL CANCER INST, (1989), vol. 81, no. 23, pages 1800 - 6
    - ZHONG L ET AL., CANCER CAUSES CONTROL, (1999), vol. 10, no. 6, pages 607 - 16
    - HENSCHKE CL ET AL., LANCET, (1999), vol. 354, no. 9173, pages 99 - 105
    - JETT JR, CLIN CANCER RES, (2005), vol. 11, no. 13, pages 4988S - 4992S
    - BHATTACHARJEE A ET AL., PROC NATL ACAD SCI U S A, (2001), vol. 98, no. 24, pages 13790 - 5
    - MEYERSON M; CARBONE D, J CLIN ONCOL, (2005), vol. 23, no. 14, pages 3219 - 26
    - BEER DG ET AL., NAT MED, (2002), vol. 8, no. 8, pages 816 - 24
    - CHEN HY ET AL., N ENGL J MED, (2007), vol. 356, no. 1, pages 11 - 20
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.